万孚生物：拟最高6000万元回购股份用于股权激励

Core Viewpoint - Wanfu Biological (300482) announced a share buyback plan using its own funds, with a total amount between RMB 30 million and RMB 60 million, aimed at implementing equity incentives or employee stock ownership plans [1] Summary by Relevant Sections Buyback Details - The buyback will be conducted through centralized bidding, with a maximum price of RMB 34.66 per share [1] - The estimated number of shares to be repurchased ranges from approximately 865,600 to 1,731,100 shares, representing about 0.18% to 0.37% of the company's total share capital [1] Financial Impact - The buyback period is set for six months from the date the board approves the final buyback plan [1] - As of June 30, 2025, the company's total assets were RMB 6.9 billion, and the net assets attributable to shareholders were RMB 5.551 billion [1] - If the upper limit of the buyback amount (RMB 60 million) is used, it would account for 0.87% of total assets and 1.08% of net assets, indicating no significant impact on the company's operations, finances, R&D, debt obligations, or future development [1] Strategic Intent - The company expressed confidence in its future development prospects, aiming to enhance its long-term incentive mechanism and promote sustainable business growth [1] - Any shares not utilized within 36 months after the buyback will be legally canceled [1]